Tarsus Pharmaceuticals Inc logo

TARS

Tarsus Pharmaceuticals Inc

$39.22

Earnings Summary

Revenue
$1.87Mn
Net Profits
$-39.15Mn
Net Profit Margins
-2092.36%

Highlights

Revenue:

Tarsus Pharmaceuticals Inc’s revenue jumped +Inf% since last year same period to $1.87Mn in the Q3 2023. On a quarterly growth basis, Tarsus Pharmaceuticals Inc has generated -87.75% fall in its revenue since last 3-months.

Net Profits:

Tarsus Pharmaceuticals Inc’s net profit fell -73.91% since last year same period to $-39.15Mn in the Q3 2023. On a quarterly growth basis, Tarsus Pharmaceuticals Inc has generated -24.58% fall in its net profits since last 3-months.

Net Profit Margins:

Tarsus Pharmaceuticals Inc’s net profit margin jumped NaN% since last year same period to -2092.36% in the Q3 2023. On a quarterly growth basis, Tarsus Pharmaceuticals Inc has generated -917.21% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Tarsus Pharmaceuticals Inc post its latest quarter earnings

EPS Estimate Current Quarter
-1.37
EPS Estimate Current Year
-1.37

Highlights

EPS Estimate Current Quarter:

Tarsus Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -1.37 - a -0.74% fall from last quarter’s estimates.

EPS Estimate Current Year:

Tarsus Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -1.37.

Key Ratios

Key ratios of the Tarsus Pharmaceuticals Inc post its Q3 2023 earnings

Earning Per Share (EPS)
-1.28

Highlights

Earning Per Share (EPS):

Tarsus Pharmaceuticals Inc’s earning per share (EPS) fell -52.38% since last year same period to -1.28 in the Q3 2023. This indicates that the Tarsus Pharmaceuticals Inc has generated -52.38% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2023-05-09
-0.94
-0.88
6.38%
2023-11-09
-1.37
-1.28
6.57%
2023-08-10
-1.08
-1.17
-8.33%